$VVX

V2X, Inc. (VVX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

V2X, Inc. (VVX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of L. Roger Mason, Jr. as Chief Growth Officer On August 7, 2026, Dr. L. Roger Mason, Jr. resigned from his pos

Original reporting
Published Aug 10, 2026, 8:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$VVX
Neutral
medium confidence
Mentioned
$VVX
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VVXNeutralLow
01

Why it matters

The disclosure quantifies a prorated target annual incentive payment and states the resignation is not due to disagreements, implying limited immediate fundamental disruption but potential near-term uncertainty on growth leadership.

02

Market read

Traders may treat this as a governance and leadership continuity update with modest impact, absent any guidance or contract changes.

03

What to watch

CEO Jeremy Wensinger will assume the role temporarily, so traders may watch for any subsequent permanent appointment or changes to growth strategy messaging.

Relevance 6/10Novelty 5/10Timing: filed Aug 10, 2026, covering an Aug 6 resignation effective immediately

Background

V2X filed an 8-K Item 5.02 detailing the resignation of its Chief Growth Officer and related compensatory arrangements.

Company-level read

Ticker impact

$VVXNeutralMedium confidence
Context

V2X disclosed Dr. L. Roger Mason Jr.’s resignation as Chief Growth Officer and a $331,975 separation payment under a release agreement.

Expected impact

Likely limited near-term impact; any move would be sentiment-driven around leadership continuity rather than fundamentals.

Evidence & confidence

The filing is an 8-K Item 5.02 with a named officer departure and quantified separation incentive, but it does not cite operational disagreement, guidance changes, or new contracts.

Market effects

Minimal sector read-through; this is an internal leadership/separation disclosure without stated program or contract changes.

None indicated.

None indicated.

Counterpoint

The resignation could reflect strategic realignment or government appointment-driven restructuring, which may not be fully captured by the separation terms alone.

Key entities

  • V2X, Inc.

    US defense services contractor that filed the 8-K regarding an officer resignation and separation payment.

  • L. Roger Mason, Jr.

    Resigned as Senior Vice President and Chief Growth Officer effective immediately to serve as Director of the National Reconnaissance Office.

  • Jeremy C. Wensinger

    CEO who will assume Mason’s role and responsibilities until a successor is appointed.

Related articles

$VVXHighAI 9/10

V2X (VVX) Lands A Long Runway With Its Latest Air Force Deal

V2X Inc. (VVX) secured a $500M contract with the US Air Force for C-12 Huron fleet services through 2031. The company reported Q2 revenue of $1.26B, up 17% YoY, and adjusted EPS of $1.64, up 23% YoY. Management raised its 2026 outlook and reduced net debt to $876.1M. The contract is a firm fixed price, transferring cost risk to V2X.

$VVXMedAI 8/10

V2X (VVX) Q2 2026 Earnings Call Transcript

V2X (VVX) reported Q2 2026 revenue of $1.26B, up 17% year over year, with adjusted net income of $51.6M (+22%) and adjusted diluted EPS of $1.64 (+23%). Management raised full-year 2026 guidance: revenue to $4.875B-$5.025B and adjusted EBITDA to $347.5M-$362.5M, plus EPS to $5.90-$6.30. Backlog totaled $12.7B.

$VVXMedAI 8/10

V2X (VVX) Q2 2026 Earnings Call Transcript

V2X (VVX) held its Q2 2026 earnings call. The company raised full-year guidance, expecting revenue and adjusted EBITDA to rise about 10% YoY at the midpoint and adjusted diluted EPS to increase 16%. Q2 revenue grew 17% to $1.26B; adjusted EBITDA was $89.8M (7.1% margin). Bookings were $600M, backlog $12.7B, and funded backlog $2.5B.

$VVXMedAI 8/10

V2X stock rises after winning Marine Corps contract

V2X Inc. (NYSE:VVX) shares rose about 1.6% after the company said it won a U.S. Marine Corps Logistics Command logistics contract worth up to $500 million. The base value is about $391 million, with options potentially bringing total value to the ceiling. V2X will provide logistics integration support for the Secondary Repairable program.